Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001104659-13-018480
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-07 18:30:57
Reporting Period:
2013-02-25
Filing Date:
2013-03-07
Filing Date Changed:
2013-03-07
Accepted Time:
2013-03-07 18:30:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1526119 Verastem, Inc. VSTM Pharmaceutical Preparations (2834) 273269467
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1291961 H Christoph Westphal C/o Verastem, Inc.
215 First Street, Suite 440
Cambridge MA 02142
Chief Executive Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-02-25 100 $9.93 739,095 No 4 L Direct
Common Stock Acquisiton 2013-02-25 259 $9.95 739,354 No 4 L Direct
Common Stock Acquisiton 2013-02-25 41 $9.96 739,395 No 4 L Direct
Common Stock Acquisiton 2013-02-25 200 $9.98 739,595 No 4 L Direct
Common Stock Acquisiton 2013-02-25 200 $9.99 739,795 No 4 L Direct
Common Stock Acquisiton 2013-03-05 800 $9.47 740,595 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 L Direct
No 4 L Direct
No 4 L Direct
No 4 L Direct
No 4 L Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,869,841 Indirect By Longwood Fund, L.P.
Common Stock 125,714 Indirect By the Fountain Irrevocable Trust of 2010
Footnotes
  1. The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 20, 2012.
  2. Represents a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $9.39 to $9.50, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 2 to this Form 4.
  3. Longwood Fund GP, LLC is the sole General Partner of Longwood Fund, L.P. Christoph Westphal, M.D., Ph.D., Richard Aldrich and Michelle Dipp, M.D., Ph.D. (collectively, the "Managers") are managers of Longwood Fund GP, LLC, and, as such, may be deemed to have shared voting and dispositive power with respect to the issuer's securities held by Longwood Fund L.P. (the "Longwood Shares"). Each of the Managers disclaims beneficial ownership of the Longwood Shares, except to the extent of their respective pecuniary interest therein, and the inclusion of the Longwood Shares in this report shall not be deemed an admission of beneficial ownership of the Longwood Shares for purposes of Section 16 or for any other purpose.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!